Von Willebrand Factor
- Authors: - -
- Issue: No 2 (2010)
- Pages: 77-79
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/245897
- ID: 245897
Cite item
Full Text
Abstract
History of discovery and clinical sighnificance of von Willebrand factor in nephrology are discussed.
References
- Keeney S., Cumming A.M. The molecular biology of von Willebrand disease. Clin. Lab. Haematol. 2001; 23(4): 209-230
- Мухин Н.А., Полянцева Л.Р., Козловская Л.В. и др. Клиническое значение изучения гемостаза в нефрологии. Тер. арх. 1988; 6: 7 - 12
- Бобкова И.Н., Полянцева Л.Р., Тареева И.Е., Козловская Л.В. Клиническое значение определения фактора Виллебранда у больных волчаночным нефритом. Тер. арх. 1995; 5: 14 - 16
- Taira K., Kamitsuji H., Okajima C., Fujimura Y. Enhanced ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib in patients with steroid-responsive nephrotic syndrome. Haemostasis. 1990; 20(4): 219-228
- Zhang J.J., Jiang L., Liu G. et al. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions. Nephrology (Carlton). 2008; 13(8): 712-720
- Mackinnon B., Deighan C.J., Norrie J. et al. The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis. Clin. Nephrol. 2005; 63(3): 173-180
- Hernández E., Toledo T., Alamo C. et al. Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition. Am. J. Kidney Dis. 1997; 30(3): 397-403
- Bertaglia G., Ossi E., Casonato A. et al. Von Willebrand factor abnormalities in IgA nephropathy. Nephrol. Dial. Transplant. 1997; 12(3): 474-479
- Бобкова И.Н., Козловская Л.В., Рамеева А.С. и др. Клиническое значение определения в моче маркеров эндотелиальной дисфункции и факторов ангиогенеза в оценке тубулоинтерстициального фиброза при хроническом гломерулонефрите. Тер. арх. 2007; 6: 10-15
- Ferraccioli G., Romano G. Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors. Lupus. 2008; 17(6): 533-540
- Козловская Н.Л. Нефропатия, ассоциированная с первичным антифосфолипидным синдромом: клинико-морфологическая характеристика, диагностика, лечение. Автореф. дисс. докт. М., 2006
- Peyvandi F., Lavoretano S., Palla R. et al. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haemotologica. 2008; 93(2): 232-239
- Sadler J.E. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood. 2008; 112(1): 11-18
- Tsai H-M. The kidney in thrombotic thrombocytopenic purpura. Minerva Med. 2007; 98(6): 731-747
- Desch K., Motto D. Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome? J. Am. Soc. Nephrol. 2007; 18: 2457-2460
Supplementary files
